Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
Zepbound, a weight loss drug, shows potential in treating obstructive sleep apnea, with trial results prompting Eli Lilly to seek FDA approval for expanded use.
Eli Lilly Offering Way Cheaper Zepbound, If You're Willing to Buy Your Own Syringes
Zepbound's new self-dosing option provides significant cost savings for patients willing to administer their own injections.
Eli Lilly's weight-loss drug may prevent diabetes - but there's 1 unanswered question
GLP-1 drugs Zepbound and Mounjaro significantly reduce diabetes risk by 94% while aiding substantial weight loss in pre-diabetic adults.
Weight loss drug Zepbound may help people with obstructive sleep apnea, drugmaker says
Zepbound, a weight loss drug, shows potential in treating obstructive sleep apnea, with trial results prompting Eli Lilly to seek FDA approval for expanded use.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
As Eli Lilly Wades Into Telehealth for Weight Loss, Doctors Are Wary
Eli Lilly has launched a new platform called LillyDirect to make it easier for patients to access its weight loss drug, Zepbound, by connecting them with telehealth providers and prescription delivery services.
The platform aims to ensure patients receive brand-name drugs and not counterfeit versions, as well as access coupons to lower the cost of the medication.
Medicare won't pay for new weight-loss drugs, putting them out of reach for older Americans
Medicare is forbidden from covering obesity drugs, but there is a bipartisan push to change that.
The cost of obesity drugs, such as Wegovy and Zepbound, is high, making them inaccessible to many.
How Much Weight Comes Back After Stopping a Weight-Loss Drug?
New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
How Much Weight Comes Back After Stopping a Weight-Loss Drug?
New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
How Much Weight Comes Back After Stopping a Weight-Loss Drug?
New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
How Much Weight Comes Back After Stopping a Weight-Loss Drug?
New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
How Much Weight Comes Back After Stopping a Weight-Loss Drug?
New research confirms that people may have to stay on the weight loss drug Zepbound for the rest of their lives to keep the weight off.
Participants who continued taking tirzepatide, the compound in Zepbound, lost more weight compared to those who switched to a placebo.
Which Weight Loss Drug Is Best And Safest? Here's What Actually Sets Them Apart
The popularity of anti-diabetes drugs repurposed for weight loss is increasing in the U.S.
The FDA approved Eli Lilly's Zepbound, which is the same as Mounjaro but used for weight loss instead.